Helus Pharma Inc. Company Profile
NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Helus Pharma at a glance
Helus Pharma Inc. (NASDAQ: HELP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Toronto, ON, Canada. Helus Pharma is led by Mr. Michael I. Halstead J.D. and employs about 100 people. At a market capitalization of $487.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001833141, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Helus Pharma do?
Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions. It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder; and HLP004, a deuterated N, N-dimethyltryptamine, which is in phase 2 clinical trial for treating generalized anxiety disorders. The company's preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluate HLP003 for the adjunctive treatment of major depressive disorder; and Osmind for mental health treatments. It operates in Canada, the United States, the United Kingdom, and Ireland. The company was formerly known as Cybin Inc. and changed its name to Helus Pharma Inc. in October 2026. Helus Pharma Inc. was founded in 2019 and is headquartered in Toronto, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- Helus Pharma Inc.
- Ticker
- NASDAQ: HELP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Michael I. Halstead J.D.
- Employees
- 100
- Headquarters
- 100 King Street West, Toronto, ON, Canada
- Phone
- 908 764 8385
- Website
- helus.com
- Market cap
- $487.68M
- SEC CIK
- 0001833141
Companies similar to Helus Pharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WVEWave Life Sciences Inc. | 2.56 | -5.88% | $504.91M | vs HELP |
| EVOEvotec SE ADR | 1.32 | -8.97% | $469.11M | vs HELP |
| MNPRMonopar Therapeutics Inc. | 69.00 | -1.84% | $467.60M | vs HELP |
| RZLTRezolute Inc. | 3.92 | -6.67% | $465.58M | vs HELP |
| ALMSAlumis Inc. | 3.96 | -8.54% | $514.09M | vs HELP |
| BLSMBlossomHill Therapeutics Inc. | 14.51 | +0.69% | $461.20M | vs HELP |
| GYREGyre Therapeutics Inc. | 4.21 | -6.86% | $460.79M | vs HELP |
| NGNENeurogene Inc. | 22.15 | -3.40% | $458.53M | vs HELP |